The latest from Mayo Clinic Laboratories
The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at firstname.lastname@example.org, attention: Mayo Clinic Laboratories.
In an article in The Globe and Mail, Matthew Binnicker, Ph.D., discussed factors that could be contributing to the recent drop in case counts.
In an article exploring the low prevalence of flu cases, Dr. Binnicker was among the experts consulted on why influenza is so scarce this year.
Jane Hermansen of Mayo Clinic Labs weighs in on a discussion of uses for expanded testing capacity after the pandemic is over.
An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.
Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic Laboratories.
Viral online posts claimed the World Health Organization changed its COVID-19 testing guidelines and admitted to inflating case counts. Dr. Binnicker helps explain why those claims are false.
Mayo Clinic Laboratories now offers multiplex testing for SARS-CoV-2 (the virus that causes COVID-19) and influenza A and B to all health care providers. This test is used to detect and differentiate between COVID-19 and influenza A and B in a single test using upper respiratory tract specimens.
At the beginning of the pandemic, pooled testing was seen as a way to potentially conserve valuable testing resources, but logistical hurdles and other challenges have limited its usefulness.
Beginning Jan. 26, all air travelers entering the U.S. from other countries will need a negative COVID-19 test result before they can board their flights.
Dr. Matthew Binnicker addresses the dramatic decrease in flu cases, and the corresponding drop in serious illness and death related to influenza, seen throughout the country this year.
Mayo Clinic Laboratories is carefully monitoring the emergence of two new variants of SARS-CoV-2 ― the virus that causes COVID-19 ― in the U.S. One variant is from the U.K. and one variant is from South Africa.
Mayo Clinic Laboratories and American Hospital Dubai announce a strategic partnership aimed at improving advanced laboratory diagnostics in the Dubai region. Under the agreement, the two organizations will begin delivering laboratory testing through a collaboration based out of American Hospital Dubai in early 2021.